A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure:: Initial experience

被引:36
作者
Castro, Pablo F.
Concepcion, Roberto
Bourge, Robert C.
Martinez, Alejandro
Alcaino, Milton
Deck, Carlos
Ferrada, Marcela
Alfaro, Mario
Perrone, Sergio
机构
[1] Pontificia Univ Catolica Chile, Santiago, Chile
[2] Hosp DIPRECA, Santiago, Chile
[3] Inst FLENI, Buenos Aires, DF, Argentina
[4] Univ Alabama, Birmingham, AL 35233 USA
关键词
D O I
10.1016/j.healun.2006.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemodynamic goals have been used in the past to guide therapy in patients with heart failure (HF). For HF patients whose signs and symptoms of congestion do not resolve with initial therapy it appears reasonable to consider hemodynamic monitoring at experienced sites. It has been suggested that implantable hemodynamic sensors may enable frequent monitoring of hemodynamic changes in HF patients and be used in tailoring vasodilator. We present the first human case of radio-frequency based, wireless pressure sensor for the monitoring of pulmonary artery pressure in patients with advanced HF. This sensor is delivered into the pulmonary artery via percutaneous venous access.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 23 条
[1]   Ongoing right ventricular hemodynarnics in heart failure -: Clinical value of measurements derived from an implantable monitoring system [J].
Adamson, PB ;
Magalski, A ;
Braunschweig, F ;
Böhm, M ;
Reynolds, D ;
Steinhaus, D ;
Luby, A ;
Linde, C ;
Ryden, L ;
Cremers, B ;
Takle, T ;
Bennett, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :565-571
[2]  
[Anonymous], HEART DIS STROK STAT
[3]  
BOURGE R, 2005, AM COLL CARD ANN SCI
[4]   The problem of decompensated heart failure: Nomenclature, classification, and risk stratification [J].
Felker, GM ;
Adams, KF ;
Konstam, MA ;
O'Connor, CM ;
Gheorghiade, M .
AMERICAN HEART JOURNAL, 2003, 145 (02) :S18-S25
[5]   EFFECT OF DIRECT VASODILATION WITH HYDRALAZINE VERSUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH CAPTOPRIL ON MORTALITY IN ADVANCED HEART-FAILURE - THE HY-C TRIAL [J].
FONAROW, GC ;
CHELIMSKYFALLICK, C ;
STEVENSON, LW ;
LUU, M ;
HAMILTON, MA ;
MORIGUCHI, JD ;
TILLISCH, JH ;
WALDEN, JA ;
ALBANESE, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :842-850
[6]   Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure [J].
Fonarow, GC ;
Stevenson, LW ;
Walden, JA ;
Livingston, NA ;
Steimle, AE ;
Hamilton, MA ;
Moriguchi, J ;
Tillisch, JH ;
Woo, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (03) :725-732
[7]  
GIBBS JSR, 1990, J AM COLL CARDIOL, V15, P51
[8]   SUSTAINED REDUCTION IN VALVULAR REGURGITATION AND ATRIAL VOLUMES WITH TAILORED VASODILATOR THERAPY IN ADVANCED CONGESTIVE-HEART-FAILURE SECONDARY TO DILATED (ISCHEMIC OR IDIOPATHIC) CARDIOMYOPATHY [J].
HAMILTON, MA ;
STEVENSON, LW ;
CHILD, JS ;
MORIGUCHI, JD ;
WALDEN, J ;
WOO, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (04) :259-263
[9]   Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure [J].
Lanzarini, L ;
Fontana, A ;
Campana, C ;
Klersy, C .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (06) :745-754
[10]  
Le Jemtel Thierry H, 2006, Circulation, V113, P1027